CLCharles E. Larsen

Charles E. Larsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charles E. Larsen has a total of 136 co-authors. Here are the top co-authors by number of shared publications:

  • Dennis R. Alford

    Program in Cellular and Molecular Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA

    6 shared publications
  • Chester A. Alper

    Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA

    5 shared publications
  • Chester A. Alper

    Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA, United States

    5 shared publications
  • Edmond J. Yunis

    Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

    5 shared publications
  • Zuheir L. Awdeh

    Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America

    4 shared publications
  • Chester A Alper

    3 shared publications

Latest Publications

  • Open Access

    Editorial: Population genomic architecture: Conserved polymorphic sequences (CPSs), not linkage disequilibrium

    by Chester A. Alper, Roger L. Dawkins, Jerzy K. Kulski, Charles E. Larsen, Sally S. Lloyd

    Editorial: Population genomic architecture: Conserved polymorphic sequences (CPSs), not linkage disequilibrium


  • Open Access

    A New Pedigree-Based SNP Haplotype Method for Genomic Polymorphism and Genetic Studies

    by Zareen Vadva, Charles E. Larsen, Bennett E. Propp, Michael R. Trautwein, Dennis R. Alford, Chester A. Alper

    Single nucleotide polymorphisms (SNPs) are usually the most frequent genomic variants. Directly pedigree-phased multi-SNP haplotypes provide a more accurate view of polymorphic population genomic structure than individual SNPs. The former are, therefore, more useful in genetic correlation with subject phenotype. We describe a new pedigree-based methodology for generating non-ambiguous SNP haplotypes for genetic study. SNP data for haplotype analysis were extracted from a larger Type 1 Diabetes Genetics Consortium SNP dataset based on minor allele frequency variation and redundancy, coverage rate (the frequency of phased haplotypes in which each SNP is defined) and genomic location. Redundant SNPs were eliminated, overall haplotype polymorphism was optimized and the number of undefined haplotypes was minimized. These edited SNP haplotypes from a region containing HLA-DRB1 (DR) and HLA-DQB1 (DQ) both correlated well with HLA-typed DR,DQ haplotypes and differentiated HLA-DR,DQ fragments shared by three pairs of previously identified megabase-length conserved extended haplotypes. In a pedigree-based genetic association assay for type 1 diabetes, edited SNP haplotypes and HLA-typed HLA-DR,DQ haplotypes from the same families generated essentially identical qualitative and quantitative results. Therefore, this edited SNP haplotype method is useful for both genomic polymorphic architecture and genetic association evaluation using SNP markers with diverse minor allele frequencies.


  • A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes

    by Chester A. Alper, Charles E. Larsen, Michael R. Trautwein, Dennis R. Alford


  • Pedigree-Defined Haplotypes and Their Applications to Genetic Studies

    by Chester A. Alper, Charles E. Larsen

    A haplotype is a string of nucleotides or alleles at nearby loci on one chromosome, usually inherited as a unit. Within the major histocompatibility complex (MHC) region on human chromosome 6p, independent population studies of multiple families have identified conserved extended haplotypes (CEHs) that segregate as long stretches (≥1 megabase) of essentially identical DNA sequence at relatively high (≥0.5 %) population frequency (“genetic fixity”). CEHs were first identified through segregation analysis in the early 1980s. In European Caucasian populations, the most frequent 30 CEHs account for at least one-third of all MHC haplotypes. These CEHs provide all of the known individual MHC susceptibility and protective genetic markers within those populations for several complex genetic diseases. Haplotypes are rigorously determined directly by sequencing single chromosomes or by Mendelian segregation analysis using families with informative genotypes. Four parental haplotypes are assigned unambiguously using genotypes from the two parents and from two of their haploidentical (to each other) children. However, the most common current technique to phase haplotypes is probabilistic statistical imputation, using unrelated subjects. Such probabilistic techniques have failed to detect CEHs and are thus of questionable value in identifying long-range haplotype structure and, consequently, genetic structure–function relationships. Finally, with haplotypes rigorously defined, association studies can determine frequencies of alleles among unrelated patient haplotypes vs. those among only unaffected family members (i.e., control alleles/haplotypes). Such studies reduce, as much as possible, the confounding effects of population stratification common to all genetic studies.


  • Open Access

    Dominant Sequences of Human Major Histocompatibility Complex Conserved Extended Haplotypes from HLA-DQA2 to DAXX

    by Charles E. Larsen, Dennis R. Alford, Michael R. Trautwein, Yanoh K. Jalloh, Jennifer L. Tarnacki, Sushruta K. Kunnenkeri, Dolores A. Fici, Edmond J. Yunis, Zuheir L. Awdeh, Chester A. Alper

    We resequenced and phased 27 kb of DNA within 580 kb of the MHC class II region in 158 population chromosomes, most of which were conserved extended haplotypes (CEHs) of European descent or contained their centromeric fragments. We determined the single nucleotide polymorphism and deletion-insertion polymorphism alleles of the dominant sequences from HLA-DQA2 to DAXX for these CEHs. Nine of 13 CEHs remained sufficiently intact to possess a dominant sequence extending at least to DAXX, 230 kb centromeric to HLA-DPB1. We identified the regions centromeric to HLA-DQB1 within which single instances of eight “common” European MHC haplotypes previously sequenced by the MHC Haplotype Project (MHP) were representative of those dominant CEH sequences. Only two MHP haplotypes had a dominant CEH sequence throughout the centromeric and extended class II region and one MHP haplotype did not represent a known European CEH anywhere in the region. We identified the centromeric recombination transition points of other MHP sequences from CEH representation to non-representation. Several CEH pairs or groups shared sequence identity in small blocks but had significantly different (although still conserved for each separate CEH) sequences in surrounding regions. These patterns partly explain strong calculated linkage disequilibrium over only short (tens to hundreds of kilobases) distances in the context of a finite number of observed megabase-length CEHs comprising half a population's haplotypes. Our results provide a clearer picture of European CEH class II allelic structure and population haplotype architecture, improved regional CEH markers, and raise questions concerning regional recombination hotspots. The human major histocompatibility complex (MHC) is a gene-dense region highly enriched in immune response genes. MHC genetic variation is among the highest in the human genome and is associated with both tissue transplant compatibility and many genetic disorders. Long-range (1–3 Mb) MHC haplotypes of essentially identical DNA sequence at relatively high (≥0.5%) population frequency (“genetic fixity”), called conserved extended haplotypes (CEHs), comprise roughly half of all European population haplotypes. We sequenced an aggregate of 27 kb over 580 kb in the MHC class II region from HLA-DQA2 to DAXX in 158 European haplotypes to quantify the breakdown of this genetic fixity in the centromeric portion of the MHC and to determine the representative nature within that region of eight previously fully or nearly fully sequenced “common” European haplotypes. We identified the dominant sequences of 13 European CEHs and determined where the “common” sequences did (or did not) represent related CEHs. We found patterns of shared sequence identity among different CEHs surrounded by fixed (for each CEH) but differing sequence. Our direct observational results for population haplotypes explain the mutual occurrence of CEHs and short (5–200 kb) blocks of fixed sequence detected by the statistical measure of linkage disequilibrium.


  • Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection

    by Julio Granados-Montiel, Joaquin Zúñiga, Jose Azocar, Edmond J. Feris, Daniel Terreros, Charles E. Larsen, Olga P. Clavijo, Alfredo Cruz-Lagunas, Derek Middleton, Chester A. Alper, et al.


  • Frequent occurrence of conserved extended haplotypes (CEHs) in two Caucasian populations

    by Ágnes Szilágyi, Zsófia Bánlaki, Éva Pozsonyi, Edmond J. Yunis, Zuheir L. Awdeh, Adrienn Hossó, Katalin Rajczy, Charles E. Larsen, Dolores A. Fici, Chester A. Alper, et al.


  • The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1

    by Zaheed Husain, M. Ann Kelly, George S. Eisenbarth, Alberto Pugliese, Zuheir L. Awdeh, Charles E. Larsen, Chester A. Alper


  • Open Access

    Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E

    by Viviana Romero, Charles E Larsen, Jonathan S Duke-Cohan, Edward A Fox, Tatiana Romero, Olga P Clavijo, Dolores A Fici, Zaheed Husain, Ingrid Almeciga, Dennis R Alford, et al.

    Background: The definition of human MHC class I haplotypes through association of HLA-A, HLA-Cw and HLA-B has been used to analyze ethnicity, population migrations and disease association.Results: Here, we present HLA-E allele haplotype association and population linkage disequilibrium (LD) analysis within the ~1.3 Mb bounded by HLA-B/Cw and HLA-A to increase the resolution of identified class I haplotypes. Through local breakdown of LD, we inferred ancestral recombination points both upstream and downstream of HLA-E contributing to alternative block structures within previously identified haplotypes. Through single nucleotide polymorphism (SNP) analysis of the MHC region, we also confirmed the essential genetic fixity, previously inferred by MHC allele analysis, of three conserved extended haplotypes (CEHs), and we demonstrated that commercially-available SNP analysis can be used in the MHC to help define CEHs and CEH fragments.Conclusion: We conclude that to generate high-resolution maps for relating MHC haplotypes to disease susceptibility, both SNP and MHC allele analysis must be conducted as complementary techniques.


  • A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease

    by Z.L. Awdeh, Edmond J. Yunis, Mark J. Audeh, Dolores Fici, Alberto Pugliese, Charles E. Larsen, Chester A. Alper